The surgical robotics maker posts better-than-expected quarterly earnings as it begins rollout of cardiac procedures.

Artificial intelligence isn't performing surgery yet, but if (when?) it does, these two companies are likely to be at the ...

This robotics company just put up another quarter of amazing growth, and the reasons to love the stock keep adding up.

Intuitive Surgical capped off the recovery in its shares with a strong Q4 2025 earnings release, lending support to the stock ...

Intuitive Surgical's pure-play robotics focus, rising da Vinci 5 utilization and 85% recurring revenues tilt the risk-reward ...

Intuitive Surgical is a pure-play leader in robotic-assisted soft-tissue surgery. The company’s da Vinci platform is its foundational asset, supporting procedures across urology, gynecology, general ...

Polen Capital Management Llc released its “Polen Focus Growth Strategy” Q4 2025 investor letter. A copy of the letter can be ...

Intuitive Surgical is a first-to-market leader in the field of surgical robotics. Medtronic is making headway with its own robot-assisted surgical system. Teradyne has a growing robotics segment and a ...

Intuitive Surgical (NASDAQ:ISRG) slipped about 5% in Wednesday trading after providing 2026 growth projections for its Da Vinci surgical systems that came slightly below analyst expectations. Warning!

The FDA 510(k) clearances for cardiac procedures cover Intuitive's latest-generation da Vinci 5 (DV5) using non-Force ...

The fusion of artificial intelligence (AI) with hardware is making robots smarter, more autonomous, and easier to program, which is dramatically reducing integration costs and boosting productivity.